Market Overview:
The global ophthalmic solution market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of eye diseases, rising awareness about eye health, and growing demand for ophthalmic drugs and solutions. By type, the prescription drugs segment is expected to account for the largest share of the global ophthalmic solution market in 2018. This segment is projected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. By application, inflammation/infection is expected to be the largest segment of the global ophthalmic solution market in 2018.
Product Definition:
An ophthalmic solution is a type of medication that is used to treat various eye conditions. It can help to relieve symptoms such as redness, itchiness, and inflammation. Ophthalmic solutions are typically made up of a combination of medications, including antibiotics, antihistamines, and corticosteroids.
Prescription Drugs:
Prescription drugs are the ones that are given to patients by doctors or sold over-the-counter with a doctor's prescription. They can be used for the treatment of various ophthalmic conditions such as glaucoma, cataract, and refractive errors. The global prescription drugs market is expected to grow at a lucrative rate during the forecast period owing to factors such as increasing geriatric population base and rising incidences of chronic diseases across the globe.
OTC Drugs:
OTC drugs are the pharmaceutical products that are sold over the counter. Ophthalmic solution is used for eye problems such as cataract, glaucoma, and refractive errors.
Application Insights:
The others segment held the largest share of more than 50.0% in 2017. The other application includes allergic conjunctivitis, corneal ulcers, dry eye syndrome and others. In most cases, these conditions are mild and can be treated with over-the-counter (OTC) drugs or topical ophthalmic solutions without the need for a prescription drug from a healthcare professional. However, in some cases where no improvement occurs after two weeks of using OTC products or where there is severe pain or discomfort when blinking or when looking directly at light, then treatment with an antibiotic may be necessary from a healthcare professional as it will help to clear up the condition within few days instead of waiting for several weeks like OTC drugs would do so naturally.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of key players, high patient awareness levels coupled with relatively higher healthcare expenditure in this region as compared to other regions. The U.S.
Asia Pacific is anticipated to witness lucrative growth over the forecast period due its huge untapped opportunities along with growing medical tourism industry in countries such as India, China, Singapore etc.
Growth Factors:
- Increasing prevalence of eye diseases and disorders: The global ophthalmic solution market is expected to grow at a CAGR of 5.5% during the forecast period due to the increasing prevalence of eye diseases and disorders. According to the World Health Organization (WHO), approximately 285 million people are visually impaired worldwide, out of which 39 million are blind and 246 million have low vision. This number is expected to increase due to the growing aging population, changing lifestyles, and rising pollution levels.
- Rising demand for technologically advanced products: The ophthalmic solution market is witnessing a shift towards technologically advanced products such as preservative-free solutions, high-performance solutions, etc., owing to their superior performance characteristics over traditional products. This is driving the demand for these products in developed countries such as the U.S., Germany, Japan, etc., where patients are increasingly becoming aware about these new technologies and their benefits over traditional ones.
Scope Of The Report
Report Attributes
Report Details
Report Title
Ophthalmic Solution Market Research Report
By Type
Prescription Drugs, OTC Drugs
By Application
Inflammation/Infection, Relieve Fatigue, Others
By Companies
Senju Pharmaceutical, Allergan, Novartis, Pfizer, Merck, Genentech, Teva, Senju Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
135
Number of Tables & Figures
95
Customization Available
Yes, the report can be customized as per your need.
Global Ophthalmic Solution Market Report Segments:
The global Ophthalmic Solution market is segmented on the basis of:
Types
Prescription Drugs, OTC Drugs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Inflammation/Infection, Relieve Fatigue, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Senju Pharmaceutical
- Allergan
- Novartis
- Pfizer
- Merck
- Genentech
- Teva
- Senju Pharmaceutical
Highlights of The Ophthalmic Solution Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Prescription Drugs
- OTC Drugs
- By Application:
- Inflammation/Infection
- Relieve Fatigue
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ophthalmic Solution Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ophthalmic solution is a type of eye medication that is used to treat various conditions affecting the eyes. Ophthalmic solution can be used to clean and dry the eyes, reduce inflammation, and relieve pain.
Some of the major companies in the ophthalmic solution market are Senju Pharmaceutical, Allergan, Novartis, Pfizer, Merck, Genentech, Teva, Senju Pharmaceutical.
The ophthalmic solution market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Ophthalmic Solution Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Ophthalmic Solution Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Ophthalmic Solution Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Ophthalmic Solution Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Ophthalmic Solution Market Size & Forecast, 2018-2028
4.5.1 Ophthalmic Solution Market Size and Y-o-Y Growth
4.5.2 Ophthalmic Solution Market Absolute $ Opportunity
Chapter 5 Global Ophthalmic Solution Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Ophthalmic Solution Market Size Forecast by Type
5.2.1 Prescription Drugs
5.2.2 OTC Drugs
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Ophthalmic Solution Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Ophthalmic Solution Market Size Forecast by Applications
6.2.1 Inflammation/Infection
6.2.2 Relieve Fatigue
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Ophthalmic Solution Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Ophthalmic Solution Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Ophthalmic Solution Analysis and Forecast
9.1 Introduction
9.2 North America Ophthalmic Solution Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Ophthalmic Solution Market Size Forecast by Type
9.6.1 Prescription Drugs
9.6.2 OTC Drugs
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Ophthalmic Solution Market Size Forecast by Applications
9.10.1 Inflammation/Infection
9.10.2 Relieve Fatigue
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Ophthalmic Solution Analysis and Forecast
10.1 Introduction
10.2 Europe Ophthalmic Solution Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Ophthalmic Solution Market Size Forecast by Type
10.6.1 Prescription Drugs
10.6.2 OTC Drugs
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Ophthalmic Solution Market Size Forecast by Applications
10.10.1 Inflammation/Infection
10.10.2 Relieve Fatigue
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Ophthalmic Solution Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Ophthalmic Solution Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Ophthalmic Solution Market Size Forecast by Type
11.6.1 Prescription Drugs
11.6.2 OTC Drugs
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Ophthalmic Solution Market Size Forecast by Applications
11.10.1 Inflammation/Infection
11.10.2 Relieve Fatigue
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Ophthalmic Solution Analysis and Forecast
12.1 Introduction
12.2 Latin America Ophthalmic Solution Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Ophthalmic Solution Market Size Forecast by Type
12.6.1 Prescription Drugs
12.6.2 OTC Drugs
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Ophthalmic Solution Market Size Forecast by Applications
12.10.1 Inflammation/Infection
12.10.2 Relieve Fatigue
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Ophthalmic Solution Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Ophthalmic Solution Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Ophthalmic Solution Market Size Forecast by Type
13.6.1 Prescription Drugs
13.6.2 OTC Drugs
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Ophthalmic Solution Market Size Forecast by Applications
13.10.1 Inflammation/Infection
13.10.2 Relieve Fatigue
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Ophthalmic Solution Market: Competitive Dashboard
14.2 Global Ophthalmic Solution Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Senju Pharmaceutical
14.3.2 Allergan
14.3.3 Novartis
14.3.4 Pfizer
14.3.5 Merck
14.3.6 Genentech
14.3.7 Teva
14.3.8 Senju Pharmaceutical
